Home > Our People > Michelle Catchur Kennedy
Our People

Michelle Catchur Kennedy

Associate

Michelle Kennedy assists clients on a variety of corporate transactions, with a focus on mergers and acquisitions. Michelle advises private equity sponsors and their portfolio companies with respect to platform acquisitions, dispositions, add-ons, and carve-outs. She also advises clients on a full range of general corporate and corporate governance matters. Michelle practices across multiple industry sectors, including healthcare, technology, consulting, education, retail, utilities, and sports.

  • Billhighway, a portfolio company of Lovell Minnick Partners, in its acquisition of ChapterSpot, a provider of CRM and member management software for fraternal organizations and chapter-based organizations
  • Fortis Payment Systems, a portfolio company of Lovell Minnick Partners, in more than eight add-on acquisitions
  • A subsidiary of KIRKBI A/S in its acquisition of FWD Media, Inc. d/b/a/ BrainPOP, a provider of an online educational platform that can be found in over two thirds of U.S. school districts as well as schools internationally
  • Lumanity, a portfolio company of Arsenal Capital Partners dedicated to improving patient health by accelerating and optimizing access to medical advances, in various strategic acquisitions and initiatives
  • Foreside Financial Group, a portfolio company of Lovell Minnick Partners and provider of an offering of distribution solutions and governance, risk management, and compliance solutions to clients in the global asset and wealth management industries, in the sale of a majority stake to Genstar Capital
  • Lovell Minnick Partners in its acquisition of Billhighway, a provider of SaaS-based accounting and transaction processing services to membership-based organizations such as fraternities, sororities, unions, and associations
  • Iron Mountain Inc. (NYSE: IRM), a provider innovative storage and information management services, in the $220 million sale of its Intellectual Property Management business to NCC Group
  • Oncoceutics, Inc., a clinical-stage biotechnology company developing imipridones, a novel class of compounds, in its sale up to $450 million to Chimerix  (Consummated January 2021)
  • Fagron in its $34 million acquisition of Letco Medical, a supplier of pharmaceutical raw materials, supplies and equipment for compounding
  • University of Pennsylvania Law School, 2017, J.D.
  • University of Florida, 2014, B.S., Business Administration, Finance, cum laude
  • Pennsylvania

Student Government Class Representative, University of Pennsylvania Law School

Member, Journal of International Law

Violinist, University of Florida Orchestra